66th ASH Annual Meeting: 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I

Symposia: Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological Oral and Poster Abstracts
Poster

Research, Bleeding and Clotting, Bleeding disorders, Adult, Clinical Practice (Health Services and Quality), Hemophilia, Assays, Genetic Disorders, Bioinformatics, Platelet disorders, Clinical Research, Pediatric, Diseases, Patient-reported outcomes, Treatment Considerations, Biological therapies, Thrombotic disorders, Clinical procedures, Adverse Events, VWD, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Molecular testing

Halls G-H (San Diego Convention Center)

1216

Athn 10 – Novel Variants in Persons with Rare Coagulation Disorders across Hemophilia Treatment Centers in the United States

Diane J. Nugent, MD¹, Shirley Williams²^*, Suchitra Acharya, MD³, Christina Ashburner²^*, Vinod V. Balasa, MBBS⁴, Nidhi Bhatt, MD⁵^*, Martin Chandler⁶^*, Tammuella Chrisentery-Singleton, MD^6,7,8, Nicole Crook, RN⁹^*, Hilda Ding, MD¹⁰, Carol Fedor, RN⁶^*, Ravitharan Krishnadasan, MD¹¹, Jonathan C. Roberts, MD¹², Beverly Schaefer, MD¹³, Ayesha Zia, MD, MSc¹⁴ and Amy D. Shapiro, MD¹⁵

¹CHOC Children's, Orange, CA
²Center for Inherited Blood Disorders, Orange, CA
³Cohen Children's Medical Center, Cohen Children's Medical Center of New York, New Hyde Park, NY
⁴Valley Children's Healthcare, Madera, CA
⁵St Jude Children's Research Hospital, Memphis, TN
⁶American Thrombosis and Hemostasis Network, Rochester, NY
⁷Ochsner Clinic Foundation, New Orleans, LA
⁸American Thrombosis and Hemostasis Network, New Orleans, LA
⁹Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders, Orange, CA
¹⁰Rady Children's Hospital, San Diego, CA
¹¹Arizona Hemophilia and Thrombosis Center, University of Arizona Health Sciences Center, Tucson, AZ
¹²Dills Family Foundation Center for Research at BCDI, The Medical College of Wisconsin Inc, Peoria, IL
¹³Oishei Children's Hospital, Roswell Park Cancer Institute, Buffalo, NY
¹⁴University of Texas Southwestern Medical Center, Dallas, TX
¹⁵Indiana Hemophilia & Thrombosis Center, Indianapolis, IN

1217

Accuracy of a Bleeding Assessment Tool in Predicting the Diagnosis of an Inherited Bleeding Disorder: Systematic Review and Meta-Analysis

Ahmad Alhuniti, MD¹, Heba Abdallah²^*, Margaret L. Rand, PhD³, Susan Kearney, MD⁴, Anjali A. Sharathkumar, MBBS, MD, MS⁵, Meera Sridharan, MD¹, Zhen Wang, Pd.D.⁶^* and Rajiv K Pruthi, M.B.B.S.^7,8

¹Mayo Clinic, Rochester, MN
²Pharmaceutical Chemistry Master Program, Florida University, Gainsville, FL
³The Hospital for Sick Children, Toronto, ON, CAN
⁴Children's Hospital and Clinics of Minnesota, Minneapolis, MN
⁵Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa Health Care, Iowa City, IA
⁶Health Care Delivery Research, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Comprehensive Hemophilia Center and Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, MN

1218

Discriminating Factors of Bleeding Disorder of Unknown Cause in a Cohort of Patients with Mild to Moderate Bleeding Disorders

Tim Dreier^*, Dino Mehic, MD^*, Justin Oosterlee, MD^*, Jasmin Sabrina Rast, MD^*, Cihan Ay^*, Ingrid Pabinger, MD and Johanna Gebhart, MD^*

Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

1219

Physician-Assessed Vs. Patient-Reported Bleeding Scores in an Undiagnosed Clinic Population

Callie Berkowitz, MD¹, Supreet Goraya, MPH²^*, Nigel S. Key, MD¹ and Alice Ma, MD¹

¹Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, NC
²University of North Carolina, Chapel Hill, NC

1220

An Equation to Distinguish Acute Blood Loss from Dilutional Changes in Serum Hemoglobin Concentration in Patients Who Receive Intravenous Fluids

David M Mueller, MD¹ and Johnson M. Liu, MD²

¹Zuckerberg Cancer Institute, Northwell Health, New Hyde Park, NY
²Tisch Cancer Institute, Mount Sinai Hospital, New york, NY

1221

Evaluation of Pharmacokinetics, Efficacy and Safety of a New Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency

Claudia Djambas Khayat, MD, BS¹^*, Heike Boehm²^*, Silke Aigner²^*, Salomon Abraha²^*, Fabian Bohlaender²^* and Joerg Schuettrumpf^2,3^*

¹Hotel Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon
²Biotest AG, Dreieich, Germany
³Grifols, Barcelona, Spain

1222

Body Mass Index As a Determinant of Clinical Outcomes in Disseminated Intravascular Coagulation: Observations from the National Inpatient Sample

Jayalekshmi Jayakumar, MD¹^*, Manasa Ginjupalli, MD²^*, Srinishant Rajarajan, MBBS³, Kalaivani Babu, MBBS³ and Arya Mariam Roy, MD⁴

¹Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY
²The Brooklyn Hospital Centre, Brooklyn, NY
³Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
⁴Ohio State University/ The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

1223

Use of Low Dose Tranexamic Acid in Patients with Bleeding Disorders

Anshul Vagrecha, MD, MBBS, Joseph Stanco, DNP^*, Mabel Origho, MD^*, Lynda Martinez^* and Suchitra Acharya, MD

Northwell Hemostasis and Thrombosis Center, New Hyde Park, NY

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

323.P1.25 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I